BME:GRFBiotechs
Grifols (BME:GRF) Stock Valuation Check After Prolonged Share Price Weakness
Recent performance snapshot and why Grifols is on investors’ radar
Grifols (BME:GRF) has drawn fresh attention after a challenging period for the stock, with the share price down about 21% year to date and about 63% over the past five years.
Over the past month, the stock is up around 1%, but it remains lower over the past 3 months and past year. This means recent gains sit within a longer stretch of weaker returns.
Against this backdrop, Grifols is reporting revenue of about €7.44b and net...